First trimester stroke prophylaxis in pregnant women with a history of stroke

Stroke

Volumn 40, Issue 4, 2009, Pages 1158-1161

  Helms, Ann K ^a   Drogan, Oksana ^b   Kittner, Steven J ^c,d,e  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b AMERICAN ACADEMY OF NEUROLOGY   (United States)

^c Clinical Center   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

All cerebrovascular disease stroke; Stroke in young adults; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

ARTICLE; FIRST TRIMESTER PREGNANCY; MEDICAL PRACTICE; MEDICAL SPECIALIST; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; STROKE; UNITED STATES; ANAMNESIS; EPIDEMIOLOGY; FEMALE; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; RISK FACTOR;

ANTICOAGULANTS; ASPIRIN; FEMALE; FIBRINOLYTIC AGENTS; HEALTH CARE SURVEYS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MEDICAL HISTORY TAKING; PLATELET AGGREGATION INHIBITORS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY TRIMESTER, FIRST; QUESTIONNAIRES; RISK FACTORS; STROKE;

EID: 65249091366     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.536425     Document Type: Article

References (24)

1. Pleis JR, Lethbridge-Cejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2006. Vital & Health Statistics - Series 10: Data From the National Health Survey. 2007;235:1-153.
2. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Guidelines for prevention of stroke in patients with ischemic stroke or TIA. Stroke. 2006;37:577-617.
3. Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium. A study of public hospitals of He de France Stroke in Pregnancy Study Group. Stroke. 1995;26:930-936.
4. Kittner SJ, Stern BJ, Feeser BR, Hebel JR, Nagey DA, Buchholz DW, Earley CJ, Johnson CJ, Macko RF, Sloan MA, Wityk RJ, Wozniak MA. Pregnancy and the risk of stroke. N Engl J Med. 1996;335:768-774.
5. C. Lamy C, Hamon JB, Coste J, Mas JL. Ischemic stroke in young women: Risk of recurrence during subsequent pregnancies. Neurology. 2000;55:269-274.
6. Anonymous. Pregnancy categories for prescription drugs. FDA Drug Bulletin. 1982;12:24-25.
7. Schiff JH, Griesa A, Ehehalt R, Elsaesser M, Katus HA, Meyer FJ. A pregnant woman with acute myocardial infarction due to coronary artery dissection: Pre-hospital and in-hospital management. Resuscitation. 2007; 73:467-474.
8. Klinzing P, Markert UR, Liesaus K, Peiker G. Successful pregnancy and delivery after myocardial infraction and essential thrombocythemia treated with clopidogrel. Clin Exp Obstet Gynecol. 2001;28:215-216.
9. Deruelle P, Denervaud M, Hachulla E, Ducloy-Bouthors A-S, Valat A-S, Puech F, Trillot N, Hatron P-Y, Subtil D. Use of low-molecular-weight heparin from the first trimester of pregnancy: a retrospective study of 111 consecutive pregnancies. Eur Journ Obstet Gyn Repro Biol. 2006;127: 73-78.
10. Hunt BJ, Doughty HA, Majumdar G, Copplestone A, Kerslake S, Buchanan N, Hughes G, Khamashta M. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Haemost. 1997;77:39-43.
11. Frydman A. Low-molecular-weight heparins: an overview of their pharma-codynamics, pharmacokinetics and metabolism in humans. Haemostasis 1996;26:24-38.
12. Ellison J, Walker ID, Greer IA. Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy. BJOG. 2000; 107:1116-1121.
13. Thomson AJ, Walker ID, Greer IA. Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy. Lancet. 1998;352:1904.
14. Shefras J, Farquharson RG. Bone density studies in pregnant women receiving heparin. Eur J Obstet Gynecol Reprod Biol. 1996;65:171-174.
15. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332:1330-1335.
16. Imperiale TF, Stollenwerk-Petrulis A. A meta-analysis of low dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA. 1991;266:260-264.
17. CLASP Collaborative Group, CLASP Coordinating Centre, Radcliffe Infirmary, Oxford. Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. Brit J Obstet Gynaecol. 1995;102:861-868.
18. Bates SM, Greer IA, Hirsh JK, Ginsberg JS. Use of antithrombotic agents during pregnancy: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:627S-644S.
19. Van Marter LJ, Leviton A, Allred EN, Pagano M, Sullivan KF, Cohen A, Epstein MF. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy Pediatrics. 1996;97:658-663.
20. Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol. 2002;187:1623-1630.
21. Nørgård B, Puhó E, Czeizel AE, Skriver MV, S0rensen HT. Aspirin use during early pregnancy and the risk of congenital abnormalities: A population-based case-control study. Am J Obstet Gynecol. 2005;192: 922-923.
22. Perkin RM, Levin DL, Clark R. Serum salicylate levels and right-to-left ductus shunts in newborn infants with persistent pulmonary hypertension. J Pediatr. 1980;96:721-726.
23. James AH, Brancazio LR, Price T. Aspirin and reproductive outcomes. Obstet Gynecol Surv. 2008;63:49-57.
24. http://www.fda.gov/cder/regulatory/pregnancy-labeling/QA.htm. Accessed July 21, 2008.